期刊文献+

人脐血间充质干细胞的体外培养及生物学特性 被引量:10

Culture and Identification of Mesenchymal Stem Cells Derived from Umbilical Cord Blood
下载PDF
导出
摘要 目的:建立一种体外纯化增殖人脐血源性间充质干细胞(MSCs)的实验方法,并观察其生物学特性。方法:从正常分娩的足月胎儿脐血中分离出MSCs进行原代培养,培养瓶预先用自体血浆包被处理。72-96 h半量更换培养液,弃去未贴壁细胞,以后每3-5 d半量换液1次。待细胞达到80%-90%融合时,按1∶2的比例进行传代。倒置或相差显微镜下每日观察原代和传代细胞的生长情况及形态学特征。取第3代脐血MSCs用流式细胞仪检测细胞周期和细胞表面抗原CD29、CD34、CD44、CD45的表达。结果:脐血经分离、培养5-7 d后有间充质样细胞贴壁,3-4周后,细胞生长达80%-90%融合,形态学类似骨髓源性MSCs。连续传至5代以后,增殖能力未见明显减弱。脐血MSCs的大部分细胞(>90%)处于G0/G1期,且均一稳定地表达间充质干细胞表面抗原CD29、CD44,但不表达CD34、CD45。结论:脐带血内含有MSCs,并可在体外纯化增殖,该技术可为实验研究和临床应用提供足够的干细胞来源。 Objective: To establish a method of purification and culturing of mesenchymal stem cells (MSCs) derived from umbilical cord blood and to investigate their biological characteristics. Methods: MSCs were obtained from umbilical cord blood of term deliveries after the mothers signed a donation form. The culture bottles were pretreated coating with self plasma. After 72-96 hours of primary culture, one half of the medium was renewed and non-adherent cells were removed. The medium was renewed by half in every 3-5 days until MSCs reached 80%-90% fusion, then they were subcultured with a propotion of 1 : 2. After the third passage, the cells were analyzed with flow cytometry. The following monocloned antibodies as CD29,CD34,CD44 and CD45 were used. The growth cycle and morphological changes of MSCs were monitored by phase contrast microscopy. Results: A cell line derived from umbilical cord blood was acquired which possessed morphological and immunophenotypical characteristics similar to those of MSCs isolated from bone marrow. The potential of proliferation remained unchanging over five passages when the cells were cultured and maintained at low differentiation. By the flow cytometric analysis, CD29 and CD44 were expressed on MSCs while no expression of CD34 and CD45 were found.Conclusion: The presence of MSCs in umbilical cord blood of term infants has been demonstrated,and MSCs can be purified and cultured in vitro for the further studies of the stem cells.
出处 《武汉大学学报(医学版)》 CAS 2007年第4期488-491,共4页 Medical Journal of Wuhan University
关键词 间充质干细胞 脐血 细胞培养 生物学特性 Mesenchymal Stem Ceils Umbilical Cord Blood Culture Biological Characterist
  • 相关文献

参考文献8

  • 1Bicknese AR,Henderson V,Sinclair-Goodwin HS,et al.Cells derived from human fetal cord blood express marker for neurons,astrocytes and oligodendrocytes[J].Exp Neurol,2001,170:199-201.
  • 2程范军,邹萍,杨汉东,余正堂,仲照东.人脐血间充质干/祖细胞诱导为心肌样细胞的实验研究[J].中华器官移植杂志,2003,24(4):220-222. 被引量:22
  • 3Ferrari G,Cusella-De-Angelis G,Coletta M,et al.Muscle regeneration by bone marrow-derived myogenic progenitors[J].Science,1998,279(5 356):1528-1530.
  • 4Huang JC,Ishida M,Hersh P,et al.Preparation and transplantation of photoreceptor sheets[J].Curr Eye Res,1998,17(6):573-585.
  • 5Kopen GC,Prockop DJ,Phinney DG.Marrow stromal cells migrate throughout forebrain and cerebellum,and they differentiate into astrocytes after injection neonatal mouse brains[J].Proc Natl Acad Sci USA,1999,96(19):10711-10716.
  • 6Areschi K,Biasin E,Piacibello W,et al.Isolation of human mesenchymal stem cells:bone marrow versus umbilical cord blood[J].Haematological,2001,86:1099-1100.
  • 7Wexler SA,Donaldson C,Denning-Kendall P,et al.Adult bone marrow is a rich source of human mesenchymal stem cells but umbillical cord and mobilized adult blood are not[J].British Journal of Haematology,2003,121(2):368-374.
  • 8江淑芳,史春梦.脐带血免疫学特性的研究进展[J].免疫学杂志,2002,18(B06):149-152. 被引量:12

二级参考文献13

  • 1Pittenger MF, Mackay AM, Beck CB, et al. Multi-lineage potential of adult human mesenchymal stem cells. Science, 1999,284: 143-147.
  • 2Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Hernatol, 2000,109:235-242.
  • 3Reys M, Lund T, Lenvik T, et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood,2001.98: 2615-2625.
  • 4Mokino S, Fududa K, Miyoshi S, et al. Cardiomyocyte can be generated from marrow stromal cell in vitro. J Clin Invest, 1999,103:697-705.
  • 5Rosenthal N, Tsao L. Helping the heart to heal with stem cells. Nat Med, 2001,7: 412-413.
  • 6Sakai T, Li RK, Weisel RD, et al. Fetal cell transplantation: a comparision of three cell types. J Thorac Cardiovase Surg, 1999,118: 715-725.
  • 7Taylor DA. Atkins BZ. Hungspreug S, et al. Regenerating functional mytrocardium: improved performance after skeletal myoblast transplantation. Nat Med, 1998,4: 929-933.
  • 8Scorsin M, Hagege A, Vilquin JP, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Candiovasc Surg,2000, 119: 1167-1175.
  • 9Kocher AA. Schuster MD, Szabolcs MJ, et al. Neovascularization of ischernic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis reduces remodeling and improves cardiac function. Nat Med, 2001, 7:430-436.
  • 10Orlic D, Kajstura J. Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. PNAS,2001, 98: 10344-10349.

共引文献32

同被引文献150

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部